1,3-Dioxoisoindolin-2-yl 2-propylpentanoate

Catalog No. :
ACYVWG342
CAS No. :
2387417-86-7
Molecular Formula :
C16H19NO4
Molecular Weight :
289.33

IUPAC Name:1,3-dioxoisoindolin-2-yl 2-propylpentanoate

1,3-Dioxoisoindolin-2-yl 2-propylpentanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$145.00Login to see priceIn stockIn stock
10g97%$232.00Login to see priceIn stockInquiry
25g97%$563.00Login to see priceIn stockIn stock
100g97%$2184.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3-Dioxoisoindolin-2-yl 2-propylpentanoate
IUPAC Name1,3-dioxoisoindolin-2-yl 2-propylpentanoate
Molecular FormulaC16H19NO4
Molecular Weight289.33
SMILESCCCC(CCC)C(ON(C(C1=C2C=CC=C1)=O)C2=O)=O
InChI KeyHTEXQWDLDIPUSM-UHFFFAOYSA-N
SynonymPentanoic acid, 2-propyl-, 1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl ester;1,3-Dioxoisoindolin-2-yl 2-propylpentanoate
CAS No.2387417-86-7
PubChem CID162624168

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACYVWG342 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYKNF271 route compound structure diagram
    --
  2. Plus
  3. ACWHOJ803 route compound structure diagram
    ACWHOJ803524-38-9 In Stock
  4. Then
  5. ACYVWG342 route product structure diagram
    ACYVWG3422387417-86-7 In Stock
Inquiry

2. ACYVWG342 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACYVWG342 route product structure diagram
    ACYVWG3422387417-86-7 In Stock
Inquiry

Comments (0)